Rick Falzone
Impact in
-
- MicroRNA in disease regulation
-
- Chronic Kidney Disease and Diabetes
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 5
- Protein Degradation and Inhibitors 2
- Signaling Pathways in Disease 1
-
- Cancer Research and Treatments 3
- Co-authors
- Jared Gollob (9 shared papers)Akshay Vaishnaw (9 shared papers)Jeff Cehelsky (7 shared papers)Clarice Kazue Fujihara (1 shared paper)Luis Paz‐Ares (2 shared papers)P. LoRusso (2 shared papers)Geoffrey I. Shapiro (3 shared papers)Márcia Silveira Graudenz (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Neurology (2 papers)Journal of the Peripheral Nervous System (1 paper)Nucleic Acid Therapeutics (1 paper)American Journal of Physiology-Renal Physiology (1 paper)
- Partner nations
- United StatesPortugalSpain
In The Last Decade
Rick Falzone
10 papers receiving 98 citations
Peers
Comparison fields: 5 of 35
- Cancer Research 27
- Nephrology 11
- Biomaterials 15
- Molecular Biology 78
- Genetics 5
Countries citing papers authored by Rick Falzone
This map shows the geographic impact of Rick Falzone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick Falzone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick Falzone more than expected).
Fields of papers citing papers by Rick Falzone
This network shows the impact of papers produced by Rick Falzone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick Falzone. The network helps show where Rick Falzone may publish in the future.
Co-authors
The 25 scholars most cited alongside Rick Falzone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 44 | |
| 2 | 2013 | 15 | |
| 3 | 1991 | 14 | |
| 4 | 2010 | 7 | |
| 5 | 2012 | 7 | |
| 6 | 2015 | 5 | |
| 7 | 2016 | 3 | |
| 8 | Interim results from phase ii trial of aln-ttr02, a novel RNAi therapeutic for the treatment of familial amyloidotic polyneuropathy | 2013 | 2 |
| 9 | ALN-TTR, an RNAI therapeutic for the treatment of transthyretin amyloidosis | 2011 | 1 |
| 10 | 2015 | 1 |
About Rick Falzone
Rick Falzone is a scholar working on Molecular Biology, Biotechnology, Cancer Research, Oncology and Surgery, having authored 10 papers that have together received 99 indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers), Cancer Genomics and Diagnostics (3 papers), Cancer Research and Treatments (3 papers), Protein Degradation and Inhibitors (2 papers), Peptidase Inhibition and Analysis (2 papers), Signaling Pathways in Disease (1 paper), Computational Drug Discovery Methods (1 paper) and Renal Diseases and Glomerulopathies (1 paper). The work is most often cited by research in Cancer Research (27 citations), Nephrology (11 citations), Biomaterials (15 citations), Molecular Biology (78 citations) and Genetics (5 citations). Rick Falzone has collaborated with scholars based in United States, Portugal and Spain. Frequent co-authors include Jared Gollob, Akshay Vaishnaw, Jeff Cehelsky, Clarice Kazue Fujihara, Luis Paz‐Ares, P. LoRusso, Geoffrey I. Shapiro, Márcia Silveira Graudenz, Roberto Zatz and Andrés Cervantes. Their work appears in journals such as Journal of Clinical Oncology, Neurology, Journal of the Peripheral Nervous System, Nucleic Acid Therapeutics and American Journal of Physiology-Renal Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.